These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 23678398)

  • 1. A holistic evolutionary and structural study of flaviviridae provides insights into the function and inhibition of HCV helicase.
    Vlachakis D; Koumandou VL; Kossida S
    PeerJ; 2013; 1():e74. PubMed ID: 23678398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An updated evolutionary study of Flaviviridae NS3 helicase and NS5 RNA-dependent RNA polymerase reveals novel invariable motifs as potential pharmacological targets.
    Papageorgiou L; Loukatou S; Sofia K; Maroulis D; Vlachakis D
    Mol Biosyst; 2016 Jun; 12(7):2080-93. PubMed ID: 26864387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular modeling and pharmacophore elucidation study of the Classical Swine Fever virus helicase as a promising pharmacological target.
    Vlachakis D; Kossida S
    PeerJ; 2013; 1():e85. PubMed ID: 23781407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viral NS3 helicase activity is inhibited by peptides reproducing the Arg-rich conserved motif of the enzyme (motif VI).
    Borowski P; Heising MV; Miranda IB; Liao CL; Choe J; Baier A
    Biochem Pharmacol; 2008 Jul; 76(1):28-38. PubMed ID: 18479669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NS3 from Hepatitis C Virus Strain JFH-1 Is an Unusually Robust Helicase That Is Primed To Bind and Unwind Viral RNA.
    Zhou T; Ren X; Adams RL; Pyle AM
    J Virol; 2018 Jan; 92(1):. PubMed ID: 29070684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C virus NS3 RNA helicase domain with a bound oligonucleotide: the crystal structure provides insights into the mode of unwinding.
    Kim JL; Morgenstern KA; Griffith JP; Dwyer MD; Thomson JA; Murcko MA; Lin C; Caron PR
    Structure; 1998 Jan; 6(1):89-100. PubMed ID: 9493270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and anti-picornaviridae in vitro activity of a new class of helicase inhibitors the N,N'-bis[4-(1H(2H)-benzotriazol-1(2)-yl)phenyl] alkyldicarboxamides.
    Carta A; Loriga M; Piras S; Paglietti G; Ferrone M; Fermeglia M; Pricl S; La Colla P; Collu G; Sanna T; Loddo R
    Med Chem; 2007 Nov; 3(6):520-32. PubMed ID: 18045201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nucleotide triphosphatase/helicase of hepatitis C virus as a target for antiviral therapy.
    Borowski P; Schalinski S; Schmitz H
    Antiviral Res; 2002 Sep; 55(3):397-412. PubMed ID: 12206878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. X-ray structure of the pestivirus NS3 helicase and its conformation in solution.
    Tortorici MA; Duquerroy S; Kwok J; Vonrhein C; Perez J; Lamp B; Bricogne G; Rümenapf T; Vachette P; Rey FA
    J Virol; 2015 Apr; 89(8):4356-71. PubMed ID: 25653438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and evaluation of ATP-binding site directed potential inhibitors of nucleoside triphosphatases/helicases and polymerases of hepatitis C and other selected Flaviviridae viruses.
    Bretner M; Schalinski S; Haag A; Lang M; Schmitz H; Baier A; Behrens SE; Kulikowski T; Borowski P
    Antivir Chem Chemother; 2004 Jan; 15(1):35-42. PubMed ID: 15074713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-based mutagenesis study of hepatitis C virus NS3 helicase.
    Lin C; Kim JL
    J Virol; 1999 Oct; 73(10):8798-807. PubMed ID: 10482634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ring-expanded ("fat") nucleoside and nucleotide analogues exhibit potent in vitro activity against flaviviridae NTPases/helicases, including those of the West Nile virus, hepatitis C virus, and Japanese encephalitis virus.
    Zhang N; Chen HM; Koch V; Schmitz H; Liao CL; Bretner M; Bhadti VS; Fattom AI; Naso RB; Hosmane RS; Borowski P
    J Med Chem; 2003 Sep; 46(19):4149-64. PubMed ID: 12954067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Theoretical study of the Usutu virus helicase 3D structure, by means of computer-aided homology modelling.
    Vlachakis D
    Theor Biol Med Model; 2009 Jun; 6():9. PubMed ID: 19555498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benzothiazole and Pyrrolone Flavivirus Inhibitors Targeting the Viral Helicase.
    Sweeney NL; Hanson AM; Mukherjee S; Ndjomou J; Geiss BJ; Steel JJ; Frankowski KJ; Li K; Schoenen FJ; Frick DN
    ACS Infect Dis; 2015 Mar; 1(3):140-148. PubMed ID: 26029739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NTPase/helicase of Flaviviridae: inhibitors and inhibition of the enzyme.
    Borowski P; Niebuhr A; Schmitz H; Hosmane RS; Bretner M; Siwecka MA; Kulikowski T
    Acta Biochim Pol; 2002; 49(3):597-614. PubMed ID: 12422230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solution structure and backbone dynamics of an engineered arginine-rich subdomain 2 of the hepatitis C virus NS3 RNA helicase.
    Liu D; Wang YS; Gesell JJ; Wyss DF
    J Mol Biol; 2001 Nov; 314(3):543-61. PubMed ID: 11846566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory mechanism of 5-bromo-3-indoleacetic acid for non-structural-3 helicase hepatitis C virus with dynamics correlation network analysis.
    Rahman MU; Rehman AU; Liu H; Chen HF
    Comput Biol Chem; 2018 Dec; 77():167-177. PubMed ID: 30326355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of RNA Helicases of ssRNA(+) Virus Belonging to Flaviviridae, Coronaviridae and Picornaviridae Families.
    Briguglio I; Piras S; Corona P; Carta A
    Int J Med Chem; 2011; 2011():213135. PubMed ID: 27516903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Replicative/transcription enzymes of Flaviviridae.
    Bressanelli S; Lescar J
    Virologie (Montrouge); 2013 Feb; 17(1):17-30. PubMed ID: 31910547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitors of the NTPase/helicases of hepatitis C and related Flaviviridae viruses.
    Bretner M; Najda A; Podwińska R; Baier A; Paruch K; Lipniacki A; Piasek A; Borowski P; Kulikowski T
    Acta Pol Pharm; 2004 Dec; 61 Suppl():26-8. PubMed ID: 15909930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.